A 12 Weeks, Randomized, Double-blind, Multi-centers, Phase III Study to Evaluate the Efficacy and Safety of Shinbaro Capsule Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee.
Phase of Trial: Phase III
Latest Information Update: 02 Jan 2018
At a glance
- Drugs GCSB 5 (Primary) ; Celecoxib
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors GC Pharma; Green Cross
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 29 Feb 2012 New trial record